[Antibiotic prophylaxis of mixed infections (aerobic-anaerobic) in gynecological surgery]. 1979

M Moroni, and N Ferrari, and V Sartor, and G Privitera, and C Belloni, and A Maggioni, and G Ortisi

UI MeSH Term Description Entries
D007044 Hysterectomy Excision of the uterus. Hysterectomies
D007045 Hysterectomy, Vaginal Removal of the uterus through the vagina. Colpohysterectomy,Colpohysterectomies,Hysterectomies, Vaginal,Vaginal Hysterectomies,Vaginal Hysterectomy
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002437 Cefazolin A semisynthetic cephalosporin analog with broad-spectrum antibiotic action due to inhibition of bacterial cell wall synthesis. It attains high serum levels and is excreted quickly via the urine. Cephazolin,Ancef,Cefamedin,Cefamezine,Cefazolin Sodium,Cephamezine,Cephazolin Sodium,Gramaxin,Kefzol,Sodium Cephazolin,Totacef,Cephazolin, Sodium,Sodium, Cefazolin,Sodium, Cephazolin
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000332 Aerobiosis Life or metabolic reactions occurring in an environment containing oxygen. Aerobioses
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

M Moroni, and N Ferrari, and V Sartor, and G Privitera, and C Belloni, and A Maggioni, and G Ortisi
October 1990, Journal of chemotherapy (Florence, Italy),
M Moroni, and N Ferrari, and V Sartor, and G Privitera, and C Belloni, and A Maggioni, and G Ortisi
April 1982, Drug intelligence & clinical pharmacy,
M Moroni, and N Ferrari, and V Sartor, and G Privitera, and C Belloni, and A Maggioni, and G Ortisi
March 1980, Lancet (London, England),
M Moroni, and N Ferrari, and V Sartor, and G Privitera, and C Belloni, and A Maggioni, and G Ortisi
March 1980, Lancet (London, England),
M Moroni, and N Ferrari, and V Sartor, and G Privitera, and C Belloni, and A Maggioni, and G Ortisi
April 1980, Lancet (London, England),
M Moroni, and N Ferrari, and V Sartor, and G Privitera, and C Belloni, and A Maggioni, and G Ortisi
February 1980, Lancet (London, England),
M Moroni, and N Ferrari, and V Sartor, and G Privitera, and C Belloni, and A Maggioni, and G Ortisi
March 1980, Lancet (London, England),
M Moroni, and N Ferrari, and V Sartor, and G Privitera, and C Belloni, and A Maggioni, and G Ortisi
May 1980, Lancet (London, England),
M Moroni, and N Ferrari, and V Sartor, and G Privitera, and C Belloni, and A Maggioni, and G Ortisi
July 1989, Journal of chemotherapy (Florence, Italy),
M Moroni, and N Ferrari, and V Sartor, and G Privitera, and C Belloni, and A Maggioni, and G Ortisi
January 1980, Infection,
Copied contents to your clipboard!